Cancer Research Cell Death Mechanisms and Cancer Therapy  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 4516-4518, September 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suganuma, M.
Right arrow Articles by Fujiki, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suganuma, M.
Right arrow Articles by Fujiki, H.
[Cancer Research 59, 4516-4518, September 15, 1999]
© 1999 American Association for Cancer Research


Advances in Brief

Essential Role of Tumor Necrosis Factor {alpha} (TNF-{alpha}) in Tumor Promotion as Revealed by TNF-{alpha}-deficient Mice1

Masami Suganuma, Sachiko Okabe, Michael W. Marino, Ayako Sakai, Eisaburo Sueoka and Hirota Fujiki2

Saitama Cancer Center Research Institute, Saitama 362-0806, Japan [M. S., S. O., E. S., H. F.]; Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [M. W. M.]; and National Institute of Health Sciences, Tokyo 158-8501, Japan [A. S.]

To examine the hypothesis that tumor necrosis factor (TNF) {alpha} is an essential cytokine in carcinogenesis, we conducted two-stage carcinogenesis experiments with an initiator, 7,12-dimethylbenz(a)anthracene (DMBA), plus either of two tumor promoters, okadaic acid and 12-O-tetradecanoylphorbol-13-acetate (TPA), on the skin of TNF-{alpha}-deficient (TNF-/-) mice. TNF-/- mice treated with DMBA plus okadaic acid developed no tumors for up to 19 weeks, and at 20 weeks, the percentage of tumor-bearing TNF-/- mice was 10%, whereas the percentage of tumor-bearing TNF+/+ mice was 100%. In TNF-/- mice treated with DMBA plus TPA, tumor onset was delayed 4 weeks, and the time to development of small tumors in 100% of mice was 9 weeks later than that seen in TNF+/+ CD-1 mice. The average number of tumors in TPA-treated TNF-/- mice was 2.8, compared with 11.8 for TNF+/+ CD-1 mice. To understand the residual tumor-promoting activity in TNF-/- mice, we also investigated the possible significance of interleukin (IL) 1 as an additional cytokine in tumor promotion. A single application of TPA and okadaic acid increased IL-1{alpha} and IL-1ß gene expression in TNF-/- mice. All of our results demonstrate that TNF-{alpha} is the key cytokine for tumor promotion in mouse skin and, very possibly, for carcinogenesis in humans as well.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. C.M. van Kruijsdijk, E. van der Wall, and F. L.J. Visseren
Obesity and Cancer: The Role of Dysfunctional Adipose Tissue
Cancer Epidemiol. Biomarkers Prev., October 1, 2009; 18(10): 2569 - 2578.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. A. Warren, S. F. Shoemaker, D. J. Shealy, W. Bshar, and M. M. Ip
Tumor necrosis factor deficiency inhibits mammary tumorigenesis and a tumor necrosis factor neutralizing antibody decreases mammary tumor growth in neu/erbB2 transgenic mice
Mol. Cancer Ther., September 1, 2009; 8(9): 2655 - 2663.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. J. Duffy, E. McKiernan, N. O'Donovan, and P. M. McGowan
Role of ADAMs in Cancer Formation and Progression
Clin. Cancer Res., February 15, 2009; 15(4): 1140 - 1144.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. B. Glick, R. Perez-Lorenzo, and J. Mohammed
Context-dependent regulation of cutaneous immunological responses by TGF{beta}1 and its role in skin carcinogenesis
Carcinogenesis, January 1, 2008; 29(1): 9 - 14.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W. Ouyang, Y. Hu, J. Li, M. Ding, Y. Lu, D. Zhang, Y. Yan, L. Song, Q. Qu, D. Desai, et al.
Direct evidence for the critical role of NFAT3 in benzo[a]pyrene diol-epoxide-induced cell transformation through mediation of inflammatory cytokine TNF induction in mouse epidermal Cl41 cells
Carcinogenesis, October 1, 2007; 28(10): 2218 - 2226.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. M. McGowan, B. M. Ryan, A. D.K. Hill, E. McDermott, N. O'Higgins, and M. J. Duffy
ADAM-17 Expression in Breast Cancer Correlates with Variables of Tumor Progression
Clin. Cancer Res., April 15, 2007; 13(8): 2335 - 2343.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Krelin, E. Voronov, S. Dotan, M. Elkabets, E. Reich, M. Fogel, M. Huszar, Y. Iwakura, S. Segal, C. A. Dinarello, et al.
Interleukin-1{beta}-Driven Inflammation Promotes the Development and Invasiveness of Chemical Carcinogen-Induced Tumors
Cancer Res., February 1, 2007; 67(3): 1062 - 1071.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Yang, M. Bocchetta, B. Kroczynska, A. G. Elmishad, Y. Chen, Z. Liu, C. Bubici, B. T. Mossman, H. I. Pass, J. R. Testa, et al.
TNF-{alpha} inhibits asbestos-induced cytotoxicity via a NF-{kappa}B-dependent pathway, a possible mechanism for asbestos-induced oncogenesis
PNAS, July 5, 2006; 103(27): 10397 - 10402.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Ohira, M. Sasaki, K. Harada, Y. Sato, Y. Zen, K. Isse, K. Kozaka, A. Ishikawa, K. Oda, Y. Nimura, et al.
Possible Regulation of Migration of Intrahepatic Cholangiocarcinoma Cells by Interaction of CXCR4 Expressed in Carcinoma Cells with Tumor Necrosis Factor-{alpha} and Stromal-Derived Factor-1 Released in Stroma
Am. J. Pathol., April 1, 2006; 168(4): 1155 - 1168.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. H. Aziz, D. L. Wheeler, B. Bhamb, and A. K. Verma
Protein Kinase C {delta} Overexpressing Transgenic Mice Are Resistant to Chemically but not to UV Radiation-Induced Development of Squamous Cell Carcinomas: A Possible Link to Specific Cytokines and Cyclooxygenase-2
Cancer Res., January 15, 2006; 66(2): 713 - 722.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. Feng, Y. Ohmori, and P.-L. Chang
Production of chemokine CXCL1/KC by okadaic acid through the nuclear factor-{kappa}B pathway
Carcinogenesis, January 1, 2006; 27(1): 43 - 52.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Y.-J. Surh, J. K. Kundu, H.-K. Na, and J.-S. Lee
Redox-Sensitive Transcription Factors as Prime Targets for Chemoprevention with Anti-Inflammatory and Antioxidative Phytochemicals
J. Nutr., December 1, 2005; 135(12): 2993S - 3001S.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. W. Chang, W.-S. Lo, and P. Lin
Trans, Trans-2,4-Decadienal, a Product Found in Cooking Oil Fumes, Induces Cell Proliferation and Cytokine Production Due to Reactive Oxygen Species in Human Bronchial Epithelial Cells
Toxicol. Sci., October 1, 2005; 87(2): 337 - 343.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Madhusudan, S. R. Muthuramalingam, J. P. Braybrooke, S. Wilner, K. Kaur, C. Han, S. Hoare, F. Balkwill, and T. S. Ganesan
Study of Etanercept, a Tumor Necrosis Factor-Alpha Inhibitor, in Recurrent Ovarian Cancer
J. Clin. Oncol., September 1, 2005; 23(25): 5950 - 5959.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Huang, S. Cao, M. Nagamani, K. E. Anderson, J. J. Grady, and L.-J. W. Lu
Decreased Circulating Levels of Tumor Necrosis Factor-{alpha} in Postmenopausal Women during Consumption of Soy-Containing Isoflavones
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3956 - 3962.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Villeneuve, P. Tremblay, and L. Vallieres
Tumor Necrosis Factor Reduces Brain Tumor Growth by Enhancing Macrophage Recruitment and Microcyst Formation
Cancer Res., May 1, 2005; 65(9): 3928 - 3936.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Zi and A. R. Simoneau
Flavokawain A, a Novel Chalcone from Kava Extract, Induces Apoptosis in Bladder Cancer Cells by Involvement of Bax Protein-Dependent and Mitochondria-Dependent Apoptotic Pathway and Suppresses Tumor Growth in Mice
Cancer Res., April 15, 2005; 65(8): 3479 - 3486.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. L. Wheeler, K. E. Martin, K. J. Ness, Y. Li, N. E. Dreckschmidt, M. Wartman, H. N. Ananthaswamy, D. L. Mitchell, and A. K. Verma
Protein Kinase C {epsilon} Is an Endogenous Photosensitizer That Enhances Ultraviolet Radiation-Induced Cutaneous Damage and Development of Squamous Cell Carcinomas1
Cancer Res., November 1, 2004; 64(21): 7756 - 7765.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. J. McCawley, H. C. Crawford, L. E. King Jr., J. Mudgett, and L. M. Matrisian
A Protective Role for Matrix Metalloproteinase-3 in Squamous Cell Carcinoma
Cancer Res., October 1, 2004; 64(19): 6965 - 6972.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. H. Lind, B. Rozell, R. P. A. Wallin, M. van Hogerlinden, H.-G. Ljunggren, R. Toftgard, and I. Sur
Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-{kappa}B inhibition
PNAS, April 6, 2004; 101(14): 4972 - 4977.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. PERVAIZ
Resveratrol: from grapevines to mammalian biology
FASEB J, November 1, 2003; 17(14): 1975 - 1985.
[Full Text] [PDF]


Home page
Cancer Res.Home page
D. L. Wheeler, K. J. Ness, T. D. Oberley, and A. K. Verma
Protein Kinase C{epsilon} Is Linked to 12-O-tetradecanoylphorbol-13-acetate-induced Tumor Necrosis Factor-{alpha} Ectodomain Shedding and the Development of Metastatic Squamous Cell Carcinoma in Protein Kinase C{epsilon} Transgenic Mice
Cancer Res., October 1, 2003; 63(19): 6547 - 6555.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Takada and B. B. Aggarwal
Betulinic Acid Suppresses Carcinogen-Induced NF-{kappa}B Activation Through Inhibition of I{kappa}B{alpha} Kinase and p65 Phosphorylation: Abrogation of Cyclooxygenase-2 and Matrix Metalloprotease-9
J. Immunol., September 15, 2003; 171(6): 3278 - 3286.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Shishodia, S. Majumdar, S. Banerjee, and B. B. Aggarwal
Ursolic Acid Inhibits Nuclear Factor-{kappa}B Activation Induced by Carcinogenic Agents through Suppression of I{kappa}B{alpha} Kinase and p65 Phosphorylation: Correlation with Down-Regulation of Cyclooxygenase 2, Matrix Metalloproteinase 9, and Cyclin D1
Cancer Res., August 1, 2003; 63(15): 4375 - 4383.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J.-E. Murphy, R. E. Morales, J. Scott, and T. S. Kupper
IL-1{alpha}, Innate Immunity, and Skin Carcinogenesis: The Effect of Constitutive Expression of IL-1{alpha} in Epidermis on Chemical Carcinogenesis
J. Immunol., June 1, 2003; 170(11): 5697 - 5703.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. Klatt and M. Serrano
Engineering cancer resistance in mice
Carcinogenesis, May 1, 2003; 24(5): 817 - 826.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. J. Thompson, J. MacGowan, M. R. Young, N. Colburn, and G. T. Bowden
A Dominant Negative c-jun Specifically Blocks Okadaic Acid-induced Skin Tumor Promotion
Cancer Res., June 1, 2002; 62(11): 3044 - 3047.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Murakami, D. Takahashi, T. Kinoshita, K. Koshimizu, H. W. Kim, A. Yoshihiro, Y. Nakamura, S. Jiwajinda, J. Terao, and H. Ohigashi
Zerumbone, a Southeast Asian ginger sesquiterpene, markedly suppresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis: the {alpha},{beta}-unsaturated carbonyl group is a prerequisite
Carcinogenesis, May 1, 2002; 23(5): 795 - 802.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Boutemmine, N. Bouchard, D. Boerboom, H. E. Jones, A. K. Goff, M. Dore, and J. Sirois
Molecular Characterization of Canine Prostaglandin G/H Synthase-2 and Regulation in Prostatic Adenocarcinoma Cells in Vitro
Endocrinology, March 1, 2002; 143(3): 1134 - 1143.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Li, J. Eckard, R. Shah, C. Malluck, and K. Frenkel
Interleukin-1{alpha} Up-Regulation in Vivo by a Potent Carcinogen 7,12-Dimethylbenz(a)anthracene (DMBA) and Control of DMBA-induced Inflammatory Responses
Cancer Res., January 1, 2002; 62(2): 417 - 423.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Suganuma, M. Kurusu, S. Okabe, N. Sueoka, M. Yoshida, Y. Wakatsuki, and H. Fujiki
Helicobacter Pylori Membrane Protein 1: A New Carcinogenic Factor of Helicobacter Pylori
Cancer Res., September 1, 2001; 61(17): 6356 - 6359.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S S Yea, Y-I Yang, W H Jang, Y J Lee, H-S Bae, and K-H Paik
Association between TNF-{alpha} promoter polymorphism and Helicobacter pylori cagA subtype infection
J. Clin. Pathol., September 1, 2001; 54(9): 703 - 706.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
B. Knight, G. C.T. Yeoh, K. L. Husk, T. Ly, L. J. Abraham, C. Yu, J. A. Rhim, and N. Fausto
Impaired Preneoplastic Changes and Liver Tumor Formation in Tumor Necrosis Factor Receptor Type 1 Knockout Mice
J. Exp. Med., December 18, 2000; 192(12): 1809 - 1818.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Murakami, Y. Nakamura, T. Tanaka, K. Kawabata, D. Takahashi, K. Koshimizu, and H. Ohigashi
Suppression by citrus auraptene of phorbol ester- and endotoxin-induced inflammatory responses: role of attenuation of leukocyte activation
Carcinogenesis, October 1, 2000; 21(10): 1843 - 1850.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. K. Manna, A. Mukhopadhyay, and B. B. Aggarwal
Resveratrol Suppresses TNF-Induced Activation of Nuclear Transcription Factors NF-{kappa}B, Activator Protein-1, and Apoptosis: Potential Role of Reactive Oxygen Intermediates and Lipid Peroxidation
J. Immunol., June 15, 2000; 164(12): 6509 - 6519.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.